INTRODUCTION
Blood monocytes are key cellular elements of the innate immune system. Besides their chemotactic, phagocytic and bactericidal function they are antigen-presenting cells (APCs). APCs display the antigen together with human leucocyte antigen (HLA) class II molecules to lymphocytes. 1, 2 Among HLA class II molecules, HLA-DR is expressed on the majority of monocytes. The HLA class II molecules present fragments of the antigens to the T cell receptor (TCR) on the surface of helper T cells, 3, 4 which use the major histocompatibility complex (MHC) class II receptor to stabilize the TCR-MHC interaction. Together with other costimulatory receptors, this event induces CD4 helper cells to secrete cytokines that, in turn, stimulate antibody production in B cells. Thus, the adaptive immune system responds to a pathogen only after it has been recognized by the innate immune system. 5 HLA class II molecules are an important link connecting the innate with the acquired immune system, which is important in priming immune responses for which immunologic memory has not been established. Expression of HLA class II antigens on the surface of hematopoietic cells is subject of ontogenetic development with HLA antigens initially detected in lymphocytes at the beginning of the second trimester. 6, 7 Since antigen presentation by monocytes is an essential component of the host defense system, we investigated HLA-DR expression on monocytes. We hypothesized low HLA-DR expression at birth because of developmental immaturity. Furthermore, we considered whether perinatal factors might influence the HLA-DR expression.
METHODS Patients
The studied population consisted of neonates admitted to the Department of Pediatrics, University Hospital of Mannheim (n ¼ 176) as well as of healthy adults (n ¼ 92). The study period included the time of admission until the 7th day of life. Neonates older than 12 hours at the time of admission and infants with severe life-threatening malformations or signs of congenital viral infections were excluded. The study was approved by the institutional ethics committee. Parents gave informed consent.
Blood samples for complete blood cell count (CBC) and C-reactive protein (CRP) determination were obtained from all infants usually on admission and subsequently as thought to be necessary by the clinicians responsible for the infant's care. Blood samples for the determination of the HLA-DR expression on monocytes were taken together with clinically indicated peripheral venipunctures during the first 7 days of life, so in case of suspected infection, whenever clinical signs of disease were present or together with screening for hypothyroidism.
Investigations for infection included a blood culture (BactAlert, Organon Teknika-Corp. Durham, Eppelheim, Germany) and when appropriate, chest or abdominal roentgenogram. Nasopharyngeal and urinary viral cultures and stool test (Rotazymet, Abbott Diagnostics, Abbott Park, IL) tests were performed when clinically indicated.
Neonates were classified into different groups:
(1) Hospitalized neonates without signs of infection and CRP<10 mg/l during the first week of life. This group was subdivided according to gestational age (g.a.):
(a) preterm neonates with g.a. <32 weeks (wks), (b) preterm neonates with g.a. between 32 and 37 weeks, and (c) term neonates.
(2) Neonates with clinical signs of infection together with CRPZ10 mg/l. 8, 9 Preeclampsia was defined as a maternal arterial pressure of greater than 140/90 mmHg, or as an increase in systolic pressure of at least 30 mmHg together with a proteinuria of >100 mg/dl in at least two random urine samples. Respiratory distress syndrome (RDS) was defined in a premature infant having clinical signs (tachypnea, retractions, flaring of the nasal alae, grunting and cyanosis) together with classic radiographic appearance of low volume lungs with a diffuse reticulogranular pattern and air bronchograms.
Blood cell counts and CRP determination
Hemotology studies included a nucleated cell count (Sysmex F 800 microcell counter, Digitana, Hamburg, Germany) and a microscopic 100-cell differential count. Absolute number of polymorphonuclear leucocytes (PMN), lymphocytes and monocytes were calculated for each white blood count (WBC) by multiplying the total white blood cells by the percentage of the components. An immature-to-total neutrophil (I/T) ratio was calculated for each WBC as the combined percentiles of immature neutrophils (band forms, metamyelocytes and myelocytes) divided by the total percentage of neutrophils in the peripheral blood.
Serum concentrations of CRP were measured using a nephelometric method (Arraytprotein system, Beckman Instruments, Mü nchen, Germany). CRP levels Z10 mg/l F repeated at least once in every child F were considered as increased.
8,9
Monocyte HLA-DR expression HLA-DR expression on monocytes was determined by flow cytometry using a standard technique for immunophenotyping. Heparinized venous blood was collected by venipuncture. Phycoerythrin-labeled CD14-antibody (CD14-PE, Becton Dickinson, Heidelberg, Germany) and FITC-labeled monoclonal anti-HLA-DRantibody (CR43/3-FITC, DAKO, Hamburg, Germany) were sequentially used for staining. Reaction was stopped by fixation of leucocytes and lysis of erythrocytes (FACS-Lysing-Solution, Becton Dickinson, Heidelberg, Germany). 10 We used a standard flow cytometer with 5 mW of 488-nm argon laser excitation (FACScant Becton Dickinson, Heidelberg, Germany). Monocytes were characterized and gated both in a forward-vs-side scatter dot plot and in a dot plot with side scatter vs PE-labeled CD14 antibody. A minimum of 2000 monocytes were acquired and analyzed for their fluorescence properties. Only CD14 strong positive monocytes were analyzed with respect to their fluorescence intensity of HLA-DR FITC. Results were expressed as relative fluorescence intensity (RFI), which represents HLA-DR expression on the cell surface ( Figure 1) .
Stability of the fluorescence channels of the FACScan was controlled by daily measurements of Calibritet-Beads (Becton Dickinson, Heidelberg, Germany). Every day we included blood of a healthy adult out of the staff or students, who gave informed consent, as a positive assay control and to obtain the standard values for adults (n ¼ 92). Isotype controls (IgG1-FITC, IgG2-PE, Dianova, Hamburg, Germany) were included as a negative assay control to identify background fluorescence.
Statistical analysis
Statistical analysis was performed using the t-test (for unpaired continuous variables, two-tailed p value) or the nonparametric Wilcoxon signed-rank test. The t-test was done in the case of normal distribution of determiniations and number of data was greater than 20 (i.e. comparison of HLA-DR expression between newborns without signs of infection and adults as well as comparison between newborns with and without signs of infection). The nonparametric Wilcoxon-signed-rank test was done for analysis of HLA-DR expression in newborns without signs of infection and perinatal factors (i.e. preeclampsia of the mother, maternal treatment with corticosteroids, mode of delivery, respiratory distress syndrome) as well as for comparison of demographic data (i.e. gestational age). For multiple comparisons, analysis of variance (ANOVA) with Bonferroni correction was done. Results are expressed as mean±standard deviation (SD).
RESULTS
We performed 262 measurements of HLA-DR expression on monocytes of 176 newborns during the first 7 days of life. Measurements were done together with blood samples taken as part of clinical care. Therefore, some of the newborns had a single measurement of HLA-DR expression, while others had two. Demographic data are shown in Table 1 .
HLA-DR expression on monocytes of hospitalized newborns without signs of infection Expression of HLA-DR molecules on monocytes of newborns was decreased during the first day of life compared with adults (RFI ¼ 67.9±36 vs 115±51.6, respectively, p<0.0001).
According to g.a, preterm newborns with g.a. less than 32 weeks had significantly lower values of HLA-DR expression during the first day of life than term newborns (RFI ¼ 49.9±28.2 vs 82.0±44.5, respectively, p ¼ 0.04) (Figure 2 ). During the first 7 days of life, HLA-DR expression on monocytes of neonates with g.a. less than 32 weeks remained low, while HLA-DR expression of newborns with g.a. 32 to 37 weeks and term newborns increased. This difference between the most premature newborns with g.a. less than 32 weeks was statistically significant when compared to newborns older than 32 weeks ( p ¼ 0.0008).
Noteworthy, HLA-DR expression during the second day of life was highest in newborns with g.a. 32 to 37 weeks (RFI ¼ 130.5±85.34 vs RFI ¼ 85.0±35 in newborns less than 32 weeks and RFI ¼ 99.0±59.3 in term newborns, p ¼ 0.39 and 0.34, respectively). At that time, HLA-DR expression of monocytes of newborns with g.a. more than 32 weeks was equal to that of adults.
Analysis of perinatal factors with respect to HLA-DR expression in newborns without signs of infection: Preeclampsia of the mother. Preeclampsia did not influence the HLA-DR expression of neonatal monocytes during the first 24 hours of life, neither in preterm newborns with g.a. less than 32 weeks nor in newborns of higher gestational age.
Maternal treatment with corticosteroids. For prevention of RDS, some of the mothers with pregnancies being at risk for preterm delivery were treated with corticosteroids to induce lung maturation of the fetus: during the first 24 hours of life, no statistically significant difference in HLA-DR expression on monocytes could be detected between neonates with and without RDS prevention, independent of gestational age (RFI ¼ 42.3±21.4 vs 60±37.8 in newborns less than 32 weeks ( p ¼ 0.46) and RFI ¼ 77.4±18.9 vs 63.4±30 in newborns with g.a. 32 to 37 weeks, p ¼ 0.21).
Mode of delivery. HLA-DR expression on monocytes of newborns delivered vaginally or by cesarean section during the first day of life was the same, independent from g.a.
Respiratory distress syndrome. Some of the preterm newborns with g.a. <32 weeks suffered from RDS and had no signs of infection. Among these newborns, HLA-DR expression on monocytes was significantly lower during the first 24 hours compared with newborns without respiratory distress (RFI ¼ 42.5±19.1 vs 69.9±28.6, respectively, p ¼ 0.037). 
HLA-DR-expression on monocytes of newborns with signs of infection
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HLA-DR Expression on Neonatal Monocytes n ¼ 2). HLA-DR expression on monocytes of newborns with confirmed and suspected infection was the same. Some of the neonates with signs of infection during the first 5 days of life had increased levels of CRP (CRP Z10 mg/l) early during the first 24 hours of life (n ¼ 49), while others later between the second and fifth day of life (n ¼ 13). Noteworthy, HLA-DR expression was depressed during the first 24 hours of life in both the groups (RFI ¼ 47.1±22.8 vs 54.0±29.1, respectively, p ¼ 0.53 without statistically significant difference).
SIGNIFICANCE
Neonatal infections substantially contribute to morbidity and mortality of newborns. We describe decreased HLA-DR expression on monocytes in preterm newborns during the first day of life as well as decreased HLA-DR expression in newborns with signs of infection and with RDS.
The neonates' increased risk of developing bacterial infections or an adverse outcome following systematic infection can, in part, be explained by their compromised immune system. Developmental immaturities in neonatal immune system affect both the innate and the acquired immune system. Antigen presentation by HLA-DR molecules of monocytes is an important link connecting the innate with the acquired immune system. 1,2,3,5,11 HLA-DR expression on monocytes is increased by interferon-g and granulocytemacrophage colony-stimulating factor, 12-14 whereas tumor necrosis factor-a, endotoxin and prostaglandin 2,14,15 downregulate HLA-DR expression.
Low HLA-DR antigen expression on cord blood monocytes of term and preterm neonates as well as of fetuses has been reported, however, without evidence for increased risk of clinical disease later in life. 11,16 -18 We report HLA-DR expression on blood monocytes of newborns with and without signs of infection and with perinatal risk factors. HLA-DR expression on monocytes was decreased in preterm newborns with g.a. less than 32 weeks. In contrast to newborns with more advanced g.a., HLA-DR expression in infants <32 weeks g.a. did not increase after the first 24 hours of life, but remained low during the whole first week of life. Reduced HLA-DR expression might be a risk factor for bacterial infection. Diminished levels of HLA-DR expression have been reported in patients suffering from sepsis. Monocytes of adult patients after surgery expressed diminished levels of HLA-DR prior to clinical signs of bacterial sepsis. [22] [23] [24] [25] Our data demonstrate that expression of HLA-DR on monocytes of newborns with signs of infection was decreased. It remains speculative, whether diminished HLA-DR expression is the result of a bacterial infection or a risk factor for the occurence of a bacterial infection. However, low expression of HLA-DR molecules has been noted in hematopoietic cells from fetal blood relative to decreasing g.a. 6, 7, 26 Thus, our findings of decreased HLA-DR expression in very premature newborns at the first day of life might reflect a continuation of fetal HLA-DR expression. The high incidence of bacterial infections in newborns 27 raises the question, whether decreased HLA-DR expression on monocytes predisposes them for bacterial infections. This is particularly true for very low birthweight infants in whom expression of HLA-DR molecules on monocytes is lowest, whereas the incidence of bacterial infections is highest. 28 Among newborns with signs of infection at the first day of life, HLA-DR expression was already decreased before levels of CRP increased. This may be in favor of an increased susceptibility to bacterial infections along with decreased HLA-DR expression. However, the time infection begins is not known exactly. Therefore, decreased HLA-DR expression may also be a result of an already ongoing infection with bacteria in the blood but without clinical signs of infection. Moreover, there is a delay of CRP synthesis after an infectious stimulation, which limits the usefulness of CRP determination as a very early marker of infection in newborns. 8, 29 Dexamethasone was reported to decrease HLA-DR expression on monocytes. 30 Therefore, we expected diminished HLA-DR expression in preterm newborns delivered after maternal treatment with corticosteroids for prevention of RDS. However, no difference was detected between preterm newborns with and without maternal treatment with steroids. The failure to detect a difference of HLA-DR expression after maternal steroid treatment may be because of the dosage administered or the time interval between treatment and delivery.
19-21
In preterm newborns with RDS, expression of HLA-DR molecules on monocytes was significantly less compared to newborns without RDS. This difference was not because of g.a. differences. During the study, all preterm newborns requiring mechanical ventilation for the treatment of RDS received surfactant (Survanta s , Abbott, IL, USA). Diminished function of blood monocytes has been reported after application of surfactant. [31] [32] [33] Additionally, mechanical ventilation itself causes a number of inflammatory responses that might influence HLA-DR expression of monocytes. Interestingly, interleukin-10 (IL-10) is detectable in early bronchoalveolar lavage samples from ventilated preterm infants 34 and IL-10 has been shown to downregulate HLA class II molecules on the surface of monocytes. 35 In conclusion, decreased expression of HLA-DR molecules on monocytes in association with a high incidence of bacterial infections in very preterm newborns suggests an important role of HLA-DR expression in the neonatal host defense system against bacterial infections. During the first week of life, the amount of HLA-DR expression reaches adult values which may reflect successful immunological adaptation to postnatal life. This adaptation seems to be disturbed in very preterm newborns, in newborns with signs of infection and in those ventilated for RDS. Iatrogenic induction of HLA-DR expression in (selected) preterm neonates could offer a means of prophylaxis of infections and RDS, respectively, and therefore should be explored.
